G8諸国の医薬品市場概要、競合分析、2018-2027年予測G8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 G8諸国の医薬品市場概要、競合分析、2018-2027年予測 概要 G8の医薬品産業プロファイルは、市場シェア、市場規模(2018~22年、2027年予測)など、トップラインの質的および量的概要情報を提供します。また... もっと見る
サマリーG8諸国の医薬品市場概要、競合分析、2018-2027年予測概要 G8の医薬品産業プロファイルは、市場シェア、市場規模(2018~22年、2027年予測)など、トップラインの質的および量的概要情報を提供します。また、主要な財務指標や市場内の競争圧力の分析を含む主要企業の説明も掲載しています。 主要ハイライト - G8諸国は2022年に世界の医薬品産業に7,747億ドル貢献し、2018年から2022年の年平均成長率(CAGR)は2.3%。G8諸国は2027年には8,974億ドルに達すると予想され、2022〜27年のCAGRは3%である。 - G8諸国の中では、米国が医薬品産業の主要国であり、2022年の市場収益は4,080億ドルである。次いで日本が923億ドル、ドイツが832億ドルである。 - 2016年のG8諸国における医薬品業界の市場規模は、米国が4,630億ドルでトップ、次いでドイツが1,079億ドル、日本が1,065億ドルと予想されている。 スコープ - G8医薬品市場の規模、成長、主要プレイヤーを特定することで、入門レベルの調査にかかる時間を節約できます。 - ファイブフォース分析により、G8医薬品市場の競争力および魅力度を把握 - 主要企業のプロファイルにより、G8医薬品市場の主要企業の事業および財務実績の詳細を明らかにします。 - G8医薬品市場の今後の成長見通しを5年予測で把握することで、プレゼンテーションやピッチに重みを加えることができます - 米国、カナダ、ドイツ、フランス、英国、イタリア、ロシア、日本のデータを比較し、各国についての個別章も掲載 購入の理由 - 2022年のG8医薬品市場規模は? - 2027年のG8医薬品市場規模は? - G8医薬品市場の競争力に影響を与える要因は何か? - 過去5年間の市場の推移は? - G8医薬品市場の上位競合企業は? 目次Table of Contents1 Introduction 1.1. What is this report about? 1.2. Who is the target reader? 1.3. How to use this report 1.4. Definitions 2 Group of Eight (G8) Pharmaceuticals 2.1. Industry Outlook 3 Pharmaceuticals in Canada 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in France 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Macroeconomic Indicators 6.1. Country data 7 Pharmaceuticals in Germany 7.1. Market Overview 7.2. Market Data 7.3. Market Segmentation 7.4. Market outlook 7.5. Five forces analysis 8 Macroeconomic Indicators 8.1. Country data 9 Pharmaceuticals in Italy 9.1. Market Overview 9.2. Market Data 9.3. Market Segmentation 9.4. Market outlook 9.5. Five forces analysis 10 Macroeconomic Indicators 10.1. Country data 11 Pharmaceuticals in Japan 11.1. Market Overview 11.2. Market Data 11.3. Market Segmentation 11.4. Market outlook 11.5. Five forces analysis 12 Macroeconomic Indicators 12.1. Country data 13 Pharmaceuticals in Russia 13.1. Market Overview 13.2. Market Data 13.3. Market Segmentation 13.4. Market outlook 13.5. Five forces analysis 14 Macroeconomic Indicators 14.1. Country data 15 Pharmaceuticals in The United Kingdom 15.1. Market Overview 15.2. Market Data 15.3. Market Segmentation 15.4. Market outlook 15.5. Five forces analysis 16 Macroeconomic Indicators 16.1. Country data 17 Pharmaceuticals in The United States 17.1. Market Overview 17.2. Market Data 17.3. Market Segmentation 17.4. Market outlook 17.5. Five forces analysis 18 Macroeconomic Indicators 18.1. Country data 19 Company Profiles 19.1. Johnson & Johnson 19.2. Apotex, Inc. 19.3. Laboratoires Pierre Fabre SA 19.4. F. Hoffmann-La Roche Ltd 19.5. Boehringer Ingelheim GmbH 19.6. A Menarini Industrie Farmaceutiche Riunite Srl 19.7. Recordati S.p.A. 19.8. Chiesi Farmaceutici SpA 19.9. Daiichi Sankyo Co Ltd 19.10. Astellas Pharma Inc. 19.11. Takeda Pharmaceutical Company Limited 19.12. Mitsubishi Tanabe Pharma Corporation 19.13. Sanofi SA 19.14. Bayer AG 19.15. Les Laboratoires Servier 19.16. Novartis AG 19.17. GSK plc. 19.18. Merck & Co., Inc. 19.19. Pfizer Inc. 19.20. AstraZeneca PLC 20 Appendix 20.1. Methodology 20.2. About MarketLine 図表リストList of TablesTable 1: G8 pharmaceuticals industry, revenue($bn), 2018-27 Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2018-22 Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2022-27 Table 4: Canada pharmaceuticals market value: $ billion, 2017-22 Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2022 Table 6: Canada pharmaceuticals market value forecast: $ billion, 2022–27 Table 7: Canada size of population (million), 2018–22 Table 8: Canada gdp (constant 2005 prices, $ billion), 2018–22 Table 9: Canada gdp (current prices, $ billion), 2018–22 Table 10: Canada inflation, 2018–22 Table 11: Canada consumer price index (absolute), 2018–22 Table 12: Canada exchange rate, 2018–22 Table 13: France pharmaceuticals market value: $ billion, 2017-22 Table 14: France pharmaceuticals market geography segmentation: $ billion, 2022 Table 15: France pharmaceuticals market value forecast: $ billion, 2022–27 Table 16: France size of population (million), 2018–22 Table 17: France gdp (constant 2005 prices, $ billion), 2018–22 Table 18: France gdp (current prices, $ billion), 2018–22 Table 19: France inflation, 2018–22 Table 20: France consumer price index (absolute), 2018–22 Table 21: France exchange rate, 2018–22 Table 22: Germany pharmaceuticals market value: $ billion, 2017-22 Table 23: Germany pharmaceuticals market geography segmentation: $ billion, 2022 Table 24: Germany pharmaceuticals market value forecast: $ billion, 2022–27 Table 25: Germany size of population (million), 2018–22 Table 26: Germany gdp (constant 2005 prices, $ billion), 2018–22 Table 27: Germany gdp (current prices, $ billion), 2018–22 Table 28: Germany inflation, 2018–22 Table 29: Germany consumer price index (absolute), 2018–22 Table 30: Germany exchange rate, 2018–22 Table 31: Italy pharmaceuticals market value: $ billion, 2017-22 Table 32: Italy pharmaceuticals market geography segmentation: $ billion, 2022 Table 33: Italy pharmaceuticals market value forecast: $ billion, 2022–27 Table 34: Italy size of population (million), 2018–22 Table 35: Italy gdp (constant 2005 prices, $ billion), 2018–22 Table 36: Italy gdp (current prices, $ billion), 2018–22 Table 37: Italy inflation, 2018–22 Table 38: Italy consumer price index (absolute), 2018–22 Table 39: Italy exchange rate, 2018–22 Table 40: Japan pharmaceuticals market value: $ billion, 2017-22 Table 41: Japan pharmaceuticals market geography segmentation: $ billion, 2022 Table 42: Japan pharmaceuticals market value forecast: $ billion, 2022–27 Table 43: Japan size of population (million), 2018–22 Table 44: Japan gdp (constant 2005 prices, $ billion), 2018–22 Table 45: Japan gdp (current prices, $ billion), 2018–22 Table 46: Japan inflation, 2018–22 Table 47: Japan consumer price index (absolute), 2018–22 Table 48: Japan exchange rate, 2018–22 Table 49: Russia pharmaceuticals market value: $ billion, 2017-22 Table 50: Russia pharmaceuticals market geography segmentation: $ billion, 2022 Table 51: Russia pharmaceuticals market value forecast: $ billion, 2022–27 Table 52: Russia size of population (million), 2018–22 Table 53: Russia gdp (constant 2005 prices, $ billion), 2018–22 Table 54: Russia gdp (current prices, $ billion), 2018–22 Table 55: Russia inflation, 2018–22 Table 56: Russia consumer price index (absolute), 2018–22 Table 57: Russia exchange rate, 2018–22 Table 58: United Kingdom pharmaceuticals market value: $ billion, 2017-22 Table 59: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022 Table 60: United Kingdom pharmaceuticals market value forecast: $ billion, 2022–27 Table 61: United Kingdom size of population (million), 2018–22 Table 62: United Kingdom gdp (constant 2005 prices, $ billion), 2018–22 Table 63: United Kingdom gdp (current prices, $ billion), 2018–22 Table 64: United Kingdom inflation, 2018–22 Table 65: United Kingdom consumer price index (absolute), 2018–22 Table 66: United Kingdom exchange rate, 2018–22 Table 67: United States pharmaceuticals market value: $ billion, 2017-22 Table 68: United States pharmaceuticals market geography segmentation: $ billion, 2022 Table 69: United States pharmaceuticals market value forecast: $ billion, 2022–27 Table 70: United States size of population (million), 2018–22 Table 71: United States gdp (constant 2005 prices, $ billion), 2018–22 Table 72: United States gdp (current prices, $ billion), 2018–22 Table 73: United States inflation, 2018–22 Table 74: United States consumer price index (absolute), 2018–22 Table 75: United States exchange rate, 2018–22 Table 76: Johnson & Johnson: key facts Table 77: Johnson & Johnson: Annual Financial Ratios Table 78: Johnson & Johnson: Key Employees Table 79: Johnson & Johnson: Key Employees Continued Table 80: Apotex, Inc.: key facts Table 81: Apotex, Inc.: Key Employees Table 82: Laboratoires Pierre Fabre SA: key facts Table 83: Laboratoires Pierre Fabre SA: Key Employees Table 84: F. Hoffmann-La Roche Ltd: key facts Table 85: F. Hoffmann-La Roche Ltd: Annual Financial Ratios Table 86: F. Hoffmann-La Roche Ltd: Key Employees Table 87: Boehringer Ingelheim GmbH: key facts Table 88: Boehringer Ingelheim GmbH: Key Employees Table 89: A Menarini Industrie Farmaceutiche Riunite Srl: key facts Table 90: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees Table 91: Recordati S.p.A.: key facts Table 92: Recordati S.p.A.: Annual Financial Ratios Table 93: Recordati S.p.A.: Key Employees Table 94: Chiesi Farmaceutici SpA: key facts Table 95: Chiesi Farmaceutici SpA: Key Employees Table 96: Daiichi Sankyo Co Ltd: key facts Table 97: Daiichi Sankyo Co Ltd: Annual Financial Ratios Table 98: Daiichi Sankyo Co Ltd: Key Employees Table 99: Daiichi Sankyo Co Ltd: Key Employees Continued Table 100: Astellas Pharma Inc.: key facts Table 101: Astellas Pharma Inc.: Annual Financial Ratios Table 102: Astellas Pharma Inc.: Key Employees Table 103: Takeda Pharmaceutical Company Limited: key facts Table 104: Takeda Pharmaceutical Company Limited: Annual Financial Ratios Table 105: Takeda Pharmaceutical Company Limited: Key Employees
SummaryG8 Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 Table of ContentsTable of Contents1 Introduction 1.1. What is this report about? 1.2. Who is the target reader? 1.3. How to use this report 1.4. Definitions 2 Group of Eight (G8) Pharmaceuticals 2.1. Industry Outlook 3 Pharmaceuticals in Canada 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in France 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Macroeconomic Indicators 6.1. Country data 7 Pharmaceuticals in Germany 7.1. Market Overview 7.2. Market Data 7.3. Market Segmentation 7.4. Market outlook 7.5. Five forces analysis 8 Macroeconomic Indicators 8.1. Country data 9 Pharmaceuticals in Italy 9.1. Market Overview 9.2. Market Data 9.3. Market Segmentation 9.4. Market outlook 9.5. Five forces analysis 10 Macroeconomic Indicators 10.1. Country data 11 Pharmaceuticals in Japan 11.1. Market Overview 11.2. Market Data 11.3. Market Segmentation 11.4. Market outlook 11.5. Five forces analysis 12 Macroeconomic Indicators 12.1. Country data 13 Pharmaceuticals in Russia 13.1. Market Overview 13.2. Market Data 13.3. Market Segmentation 13.4. Market outlook 13.5. Five forces analysis 14 Macroeconomic Indicators 14.1. Country data 15 Pharmaceuticals in The United Kingdom 15.1. Market Overview 15.2. Market Data 15.3. Market Segmentation 15.4. Market outlook 15.5. Five forces analysis 16 Macroeconomic Indicators 16.1. Country data 17 Pharmaceuticals in The United States 17.1. Market Overview 17.2. Market Data 17.3. Market Segmentation 17.4. Market outlook 17.5. Five forces analysis 18 Macroeconomic Indicators 18.1. Country data 19 Company Profiles 19.1. Johnson & Johnson 19.2. Apotex, Inc. 19.3. Laboratoires Pierre Fabre SA 19.4. F. Hoffmann-La Roche Ltd 19.5. Boehringer Ingelheim GmbH 19.6. A Menarini Industrie Farmaceutiche Riunite Srl 19.7. Recordati S.p.A. 19.8. Chiesi Farmaceutici SpA 19.9. Daiichi Sankyo Co Ltd 19.10. Astellas Pharma Inc. 19.11. Takeda Pharmaceutical Company Limited 19.12. Mitsubishi Tanabe Pharma Corporation 19.13. Sanofi SA 19.14. Bayer AG 19.15. Les Laboratoires Servier 19.16. Novartis AG 19.17. GSK plc. 19.18. Merck & Co., Inc. 19.19. Pfizer Inc. 19.20. AstraZeneca PLC 20 Appendix 20.1. Methodology 20.2. About MarketLine List of Tables/GraphsList of TablesTable 1: G8 pharmaceuticals industry, revenue($bn), 2018-27 Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2018-22 Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2022-27 Table 4: Canada pharmaceuticals market value: $ billion, 2017-22 Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2022 Table 6: Canada pharmaceuticals market value forecast: $ billion, 2022–27 Table 7: Canada size of population (million), 2018–22 Table 8: Canada gdp (constant 2005 prices, $ billion), 2018–22 Table 9: Canada gdp (current prices, $ billion), 2018–22 Table 10: Canada inflation, 2018–22 Table 11: Canada consumer price index (absolute), 2018–22 Table 12: Canada exchange rate, 2018–22 Table 13: France pharmaceuticals market value: $ billion, 2017-22 Table 14: France pharmaceuticals market geography segmentation: $ billion, 2022 Table 15: France pharmaceuticals market value forecast: $ billion, 2022–27 Table 16: France size of population (million), 2018–22 Table 17: France gdp (constant 2005 prices, $ billion), 2018–22 Table 18: France gdp (current prices, $ billion), 2018–22 Table 19: France inflation, 2018–22 Table 20: France consumer price index (absolute), 2018–22 Table 21: France exchange rate, 2018–22 Table 22: Germany pharmaceuticals market value: $ billion, 2017-22 Table 23: Germany pharmaceuticals market geography segmentation: $ billion, 2022 Table 24: Germany pharmaceuticals market value forecast: $ billion, 2022–27 Table 25: Germany size of population (million), 2018–22 Table 26: Germany gdp (constant 2005 prices, $ billion), 2018–22 Table 27: Germany gdp (current prices, $ billion), 2018–22 Table 28: Germany inflation, 2018–22 Table 29: Germany consumer price index (absolute), 2018–22 Table 30: Germany exchange rate, 2018–22 Table 31: Italy pharmaceuticals market value: $ billion, 2017-22 Table 32: Italy pharmaceuticals market geography segmentation: $ billion, 2022 Table 33: Italy pharmaceuticals market value forecast: $ billion, 2022–27 Table 34: Italy size of population (million), 2018–22 Table 35: Italy gdp (constant 2005 prices, $ billion), 2018–22 Table 36: Italy gdp (current prices, $ billion), 2018–22 Table 37: Italy inflation, 2018–22 Table 38: Italy consumer price index (absolute), 2018–22 Table 39: Italy exchange rate, 2018–22 Table 40: Japan pharmaceuticals market value: $ billion, 2017-22 Table 41: Japan pharmaceuticals market geography segmentation: $ billion, 2022 Table 42: Japan pharmaceuticals market value forecast: $ billion, 2022–27 Table 43: Japan size of population (million), 2018–22 Table 44: Japan gdp (constant 2005 prices, $ billion), 2018–22 Table 45: Japan gdp (current prices, $ billion), 2018–22 Table 46: Japan inflation, 2018–22 Table 47: Japan consumer price index (absolute), 2018–22 Table 48: Japan exchange rate, 2018–22 Table 49: Russia pharmaceuticals market value: $ billion, 2017-22 Table 50: Russia pharmaceuticals market geography segmentation: $ billion, 2022 Table 51: Russia pharmaceuticals market value forecast: $ billion, 2022–27 Table 52: Russia size of population (million), 2018–22 Table 53: Russia gdp (constant 2005 prices, $ billion), 2018–22 Table 54: Russia gdp (current prices, $ billion), 2018–22 Table 55: Russia inflation, 2018–22 Table 56: Russia consumer price index (absolute), 2018–22 Table 57: Russia exchange rate, 2018–22 Table 58: United Kingdom pharmaceuticals market value: $ billion, 2017-22 Table 59: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022 Table 60: United Kingdom pharmaceuticals market value forecast: $ billion, 2022–27 Table 61: United Kingdom size of population (million), 2018–22 Table 62: United Kingdom gdp (constant 2005 prices, $ billion), 2018–22 Table 63: United Kingdom gdp (current prices, $ billion), 2018–22 Table 64: United Kingdom inflation, 2018–22 Table 65: United Kingdom consumer price index (absolute), 2018–22 Table 66: United Kingdom exchange rate, 2018–22 Table 67: United States pharmaceuticals market value: $ billion, 2017-22 Table 68: United States pharmaceuticals market geography segmentation: $ billion, 2022 Table 69: United States pharmaceuticals market value forecast: $ billion, 2022–27 Table 70: United States size of population (million), 2018–22 Table 71: United States gdp (constant 2005 prices, $ billion), 2018–22 Table 72: United States gdp (current prices, $ billion), 2018–22 Table 73: United States inflation, 2018–22 Table 74: United States consumer price index (absolute), 2018–22 Table 75: United States exchange rate, 2018–22 Table 76: Johnson & Johnson: key facts Table 77: Johnson & Johnson: Annual Financial Ratios Table 78: Johnson & Johnson: Key Employees Table 79: Johnson & Johnson: Key Employees Continued Table 80: Apotex, Inc.: key facts Table 81: Apotex, Inc.: Key Employees Table 82: Laboratoires Pierre Fabre SA: key facts Table 83: Laboratoires Pierre Fabre SA: Key Employees Table 84: F. Hoffmann-La Roche Ltd: key facts Table 85: F. Hoffmann-La Roche Ltd: Annual Financial Ratios Table 86: F. Hoffmann-La Roche Ltd: Key Employees Table 87: Boehringer Ingelheim GmbH: key facts Table 88: Boehringer Ingelheim GmbH: Key Employees Table 89: A Menarini Industrie Farmaceutiche Riunite Srl: key facts Table 90: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees Table 91: Recordati S.p.A.: key facts Table 92: Recordati S.p.A.: Annual Financial Ratios Table 93: Recordati S.p.A.: Key Employees Table 94: Chiesi Farmaceutici SpA: key facts Table 95: Chiesi Farmaceutici SpA: Key Employees Table 96: Daiichi Sankyo Co Ltd: key facts Table 97: Daiichi Sankyo Co Ltd: Annual Financial Ratios Table 98: Daiichi Sankyo Co Ltd: Key Employees Table 99: Daiichi Sankyo Co Ltd: Key Employees Continued Table 100: Astellas Pharma Inc.: key facts Table 101: Astellas Pharma Inc.: Annual Financial Ratios Table 102: Astellas Pharma Inc.: Key Employees Table 103: Takeda Pharmaceutical Company Limited: key facts Table 104: Takeda Pharmaceutical Company Limited: Annual Financial Ratios Table 105: Takeda Pharmaceutical Company Limited: Key Employees
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketLine 社の最新刊レポート本レポートと同じKEY WORD(competitive analysis)の最新刊レポートよくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン(MarketLine)は、世界の産業および企業を国別や業種別に詳細に調査し、調査レポートを積極的に出版しています。また世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |